1. Volume 63, Issue 6, Pages 998-1008 (June 2013)
Selecting the Optimal Candidate for Adjuvant Radiotherapy After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis 
Firas Abdollah, Nazareno Suardi, Cesare Cozzarini, Andrea Gallina, Umberto Capitanio, Marco Bianchi, Maxine Sun, Nicola Fossati, Niccolò Maria Passoni, Claudio Fiorino, Nadia Di Muzio, Pierre I. Karakiewicz, Patrizio Rigatti, Francesco Montorsi, Alberto Briganti 
European Urology 
Volume 63, Issue 6, Pages (June 2013)
DOI: /j.eururo
Copyright © 2012 European Association of Urology Terms and Conditions

2. Fig. 1
Nomogram predicting 5- and 10-yr cancer-specific mortality (CSM)–free rate in patients with high-risk prostate cancer treated with radical prostatectomy and extended pelvic lymph node dissection. Total point values are calculated for each end point and then applied to the corresponding probability scale at the bottom of the figure. To obtain the nomogram-predicted probability of 5- and 10-yr CSM-free rates, locate patient values at each axis. Draw a vertical line to the Point axis to determine how many points are attributed for each variable value. Sum the points for all variables. Locate the sum on the Total points line to assess the corresponding individual probability of 5- and 10-yr CSM-free rates.
European Urology  , DOI: ( /j.eururo )
Copyright © 2012 European Association of Urology Terms and Conditions

3. Fig. 2
Calibration plot depicting the relationship between the nomogram-predicted versus observed (A) 5-yr cancer-specific mortality (CSM)–free rate and (B) 10-yr CSM-free rate.
European Urology  , DOI: ( /j.eururo )
Copyright © 2012 European Association of Urology Terms and Conditions

4. Fig. 3
Kaplan–Meier plots depicting cancer-specific mortality-free rates, after stratification according to the number of risk factors, in the entire cohort of 1049 patients treated with radical prostatectomy and extended pelvic lymph node dissection. CI=confidence interval; CSM=cancer-specific mortality; RF=risk factor.
European Urology  , DOI: ( /j.eururo )
Copyright © 2012 European Association of Urology Terms and Conditions

5. Fig. 4
Kaplan–Meier plots depicting cancer-specific mortality-free rates, after stratification according to adjuvant radiotherapy status, in a cohort of patients treated with radical prostatectomy and extended pelvic lymph node dissection and having (A) two or more risk factors (n=360) or (B) fewer than two risk factors (n=689). ART=adjuvant radiotherapy; CI=confidence interval; CSM=cancer-specific mortality.
European Urology  , DOI: ( /j.eururo )
Copyright © 2012 European Association of Urology Terms and Conditions

6. Fig. 5
Kaplan–Meier plots depicting overall mortality-free rates, after stratification according to adjuvant radiotherapy status, in a cohort of patients treated with radical prostatectomy and extended pelvic lymph node dissection and (A) two or more risk factors (n=360) or (B) fewer than two risk factors (n=689). ART=adjuvant radiotherapy.
European Urology  , DOI: ( /j.eururo )
Copyright © 2012 European Association of Urology Terms and Conditions